August 5, 2024
LONDON/NEW YORK (Reuters) – As Eli Lilly’s weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk’s Wegovy, some doctors say their guiding principle for […]
August 5, 2024
VIENNA — Nipocalimab, iscalimab, and tibulizumab, but not lusvertikimab, appear to be promising new agents for Sjögren disease that warrant further investigation, suggest the results of […]
August 5, 2024
TOPLINE: Chronic exposure to air pollutants such as fine particulate matter ≤ 2.5 μm in diameter (PM2.5), particulate matter ≤ 10 μm in diameter (PM10), nitrogen […]
August 5, 2024
TOPLINE: In a network meta-analysis (NMA) from a living systematic review, lebrikizumab and dupilumab showed similar efficacy in patients with atopic dermatitis (AD). METHODOLOGY: Researchers evaluated […]
August 5, 2024
TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]
August 5, 2024
TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]
August 2, 2024
The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat advanced synovial sarcoma. Afami-cel — the first engineered cell therapy […]
August 2, 2024
A multicomponent nonpharmaceutical intervention improves sleep in people with dementia living at home, early results of a new phase 3 randomized controlled trial (RCT) show. The […]
August 2, 2024
TOPLINE: Oncologists show significant variability in prescribing systemic cancer therapies in the last 30 days of life. Patients treated by oncologists in the top quartile for […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487
Next page